211 Programs
-
Oncology Nursing Update
What Is Molecular Residual Disease Analysis and Why Is It Clinically Relevant in Colorectal Cancer?
-
-
C
-
C
-
-
Microlearning Activity
Recent Developments in the Management of Relapsed/Refractory Multiple Myeloma from ASH 2025: BCMA-Targeted Therapy and Investigational Agents
-
-
S
-
S
-
-
S
-
S
-
-
5-Minute Journal Club
Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays in the Treatment of Breast Cancer
-
-
L
-
L
-
-
Oncology Today with Dr Neil Love
Current and Future Role of CD19 x CD3 Bispecific T-Cell Engaging Antibodies in the Treatment of Acute Lymphoblastic Leukemia
-
-
B
-
B
-
-
B
-
B
-